A Long-term Study for Participants Previously Treated with Ciltacabtagene Autoleucel
Phase 3
Recruiting
- Conditions
- Multiple Myeloma
- Registration Number
- JPRN-jRCT2033220220
- Lead Sponsor
- Ei Fujikawa
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 228
Inclusion Criteria
Participants who have received at least one dose of cilta-cel in a Company-sponsored clinical study
- Participants who have provided informed consent for this study
Exclusion Criteria
N/A
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method